Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site release label Revision: v3.6.6 was added to the history, and the previous label Revision: v3.6.5 was removed, reflecting an update to the release notes shown in the history view.
    Difference
    0.1%
    Check dated 2026-08-29T18:49:38.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.5, is added to the study history. The previous entry, Revision: v3.6.4, is removed.
    Difference
    0.1%
    Check dated 2026-08-08T09:53:18.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New revision entry 'Revision: v3.6.4' was added to the record history for the study page. The previous 'Revision: v3.6.3' entry was removed from the history.
    Difference
    0.1%
    Check dated 2026-07-25T05:28:03.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The study record history shows a new revision entry for v3.6.3 and the previous v3.6.2 is removed. This reflects an update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:03.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A new version entry v3.6.2 was added to the study record history, and the previous version v3.6.0 was removed, updating the version history for the study.
    Difference
    0.1%
    Check dated 2026-06-26T19:43:26.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Recruitment is now closed for participants. A new revision (v3.6.0) has been added and the previous revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T11:41:07.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.